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Abstract
The rapid appearance of resistant malarial parasites after introduction of atovaquone (ATQ) drug has prompted the search
for new drugs as even single point mutations in the active site of Cytochrome b protein can rapidly render ATQ ineffective.
The presence of Y268 mutations in the Cytochrome b (Cyt b) protein is previously suggested to be responsible for the ATQ
resistance in Plasmodium falciparum (P. falciparum). In this study, we examined the resistance mechanism against ATQ in P.
falciparum through computational methods. Here, we reported a reliable protein model of Cyt bc1 complex containing Cyt
b and the Iron-Sulphur Protein (ISP) of P. falciparum using composite modeling method by combining threading, ab initio
modeling and atomic-level structure refinement approaches. The molecular dynamics simulations suggest that Y268S
mutation causes ATQ resistance by reducing hydrophobic interactions between Cyt bc1 protein complex and ATQ.
Moreover, the important histidine contact of ATQ with the ISP chain is also lost due to Y268S mutation. We noticed the
induced mutation alters the arrangement of active site residues in a fashion that enforces ATQ to find its new stable binding
site far away from the wild-type binding pocket. The MM-PBSA calculations also shows that the binding affinity of ATQ with
Cyt bc1 complex is enough to hold it at this new site that ultimately leads to the ATQ resistance.
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Introduction
Studies revealed that human malaria is caused by protozoan
parasites of the genus Plasmodium. The four most common
Plasmodium species that infect human are P. vivax, P. ovale, P.
malariae, and P. falciparum. Additionally, a fifth one P. knowlesi
has also been identified as responsible for infection in human [1]
often in many countries of Southeast Asia [2]. According to the
latest World malaria report (2012) by World health organization,
there were about 219 million cases of malaria in 2010 and an
estimated 660 000 deaths. P. falciparum predominates in Africa
and is the most deadly form leading to death due to malaria. 90%
of malaria occurs in Africa and among which 85% deaths happen
in children under the age of 5 [3].
Plasmodium species can acquire drug resistance through several
mechanisms, like change in drug permeability, increased expres-
sion of the drug target, or changes in the enzyme target [4]. ATQ
drug acts against malarial parasites by inhibiting mitochondrial
electron transport [5] and collapsing mitochondrial membrane
potential [6]. Based on its structural similarity to ubiquinol, it has
been postulated that ATQ binds to parasite Cyt b protein [7]. It is
supported by experimental findings that mutations at 268th
position in P. falciparum Cyt b are unambiguously associated
with acquired ATQ resistance [8]. However, the mechanism of
ATQ resistance is still not well understood. Thus, there is an
urgent need to develop novel disease management strategies
against various Plasmodium sp induced malaria.
In several studies [9–11], researchers have modeled some P.
falciparum mutations including Y268S using in silico methods,
however none of them have completely modeled the P. falciparum
Cyt bc1 complex rather they rely on the ATQ-bound yeast Cyt
bc1 complex. Moreover, none of the study has examined the
dynamics of the Cyt bc1 ATQ-bound complex. Therefore in the
present study, we exploited the in silico approaches to identify
molecular basis of ATQ drug resistance in the Y286S mutation
model of Cyt b protein of P. falciparum. To best of our
knowledge, this is the first study to report the modeling and
molecular dynamics simulation of ATQ-bound P. falciparum Cyt
bc1 complex in both wild and mutant-type models for nanosec-
onds time scale.
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Materials and Methods
Computational model building and quality assessment
The ubiquinol oxidation (Qo) site of the Cytochrome bc1
complex serves as a pocket for ATQ binding [11] and two subunits
of the complex (Cyt b and ISP) are involved in ATQ binding
[11,12]. To model the whole complex, amino acid sequences of P.
falciparum Cyt b (Genbank accession no: NP_059668.1) and
ubiquinol-Cyt C reductase ISP subunit (Genbank accession no:
XP_001348547.1) were retrieved from the Entrez protein
database available at NCBI (http://www.ncbi.nlm.nih.gov). In
the process of protein modeling, we observed that no single
template was able to satisfy ,100% query coverage. Hence, the
composite modeling which combines various techniques such as
threading, ab initio modeling and atomic-level structure refine-
ment approaches [13–16] implemented in the iterative threading
assembly refinement (I-TASSER) server was preferred to build the
full-length protein structure of both the protein chains. I-TASSER
generates 3D atomic models from multiple threading alignments
and iterative structural assembly simulations. The full methodol-
ogy of the server has been described elsewhere [17]. The template
modeling score (TM-score) calculation [18] was used to assess the
structural similarity of model and template protein structures [Eq.
i].
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where L is the length of the target protein, Lali is the number of the
equivalent residues in two proteins, di is the distance of the ith pair
of the equivalent residues between the two structures, which
depends on the superposition matrix; the ‘max’ means the
procedure to identify the optimal superposition matrix that
superposition matrix that maximizes the sum in Eq. i. The scale
d0=
3!(L – 15) – 1.8d is defined to normalize the TM-score in a
way that the magnitude of the average TM-score for random
protein pairs is independent on the size of the proteins.
Confidence score (C-score) was taken into consideration to
determine the accuracy of the predicted structure. The score is
defined based on the quality of the threading alignments and the
convergence of the I-TASSER’s structural assembly refinement
simulations [Eq. ii].
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Where M is the number of structure decoys in the cluster and
Mtot is the total number of decoys generated during the I-TASSER
simulations. ,RMSD. is the average RMSD of the decoys to the
cluster centroid. Z(i) is the Z-score of the best template generated
by ith threading in the seven LOMETS programs and Z0(i) is a
program-specified Z-score cutoff for distinguishing between good
and bad templates.
The geometry of the theoretical model was improved by side-
chain geometry optimization using the ChiRotor algorithm [19].
The modeled structures were further subjected to energy
minimization followed by model quality estimation. In order to
further design the Cyt b-ISP complex from the individually
modeled structures of Cyt b and ISP subunits from P. falciparum,
we superimposed them to the S. cerevisiae bc1 complex already
available in Protein Data Bank (pdb entry: 3CX5). From this
superimposed structure, we got the coordinates of modelled Cyt b
and ISP subunits of P. falciparum in the orientation similar to the
one found in Cyt bc1 complex of S. cerevisiae. Since the yeast bc1
complex also strongly interacts with water molecules in the vicinity
of Glu 272 [20], the water molecule was also added to the modeled
P. falciparum Cyt b-ISP complex before performing the docking
experiments.
Mutation mapping of Cyt b protein at 268th position
All the known point mutations observed at position 268 of P.
falciparum Cyt b were individually incorporated in the modeled
3D protein structure to scan their impact on ATQ binding. For
this, all the mutant models of the Cyt b protein of P. falciparum
were generated using the mutational modeling protocol of DS3.1.
The Build Mutants protocol mutates selected residues to specified
types and optimizes the conformation of the mutated residues and
their neighbors using MODELER program.
Retrieval of ATQ structure and modeling of Cyt bc1
complex
PubChem Compound, one of the linked databases within the
NCBI’s Entrez information retrieval system was accessed for the
retrieval of ATQ structure. Both the protein and ligand molecules
were prepared before being subjected to docking analysis using
Prepare Protein and Prepare Ligand protocols of DS3.1 respec-
tively. Prepare Protein protocol rectify the protein for various
problems, such as missing atoms in incomplete residues; missing
loop regions; alternate conformations (disorder); nonstandard
atom names; incorrect protonation state of titratable residues
etc. The generation of 3D conformation of ATQ was attained by
the Prepare Ligands tool.
Molecular docking experiments of the ATQ into the Qo site of
both mutated and non-mutated variants of the Cyt b protein was
performed by CDOCKER, a molecular dynamics (MD) simulat-
ed-annealing-based algorithm [22]. The ATQ was assumed to
bind in the same binding pocket to that of ligand stigmatellin, a
known inhibitor of Qo site of the Cyt bc1 complex. Water
molecules were removed, except HOH7187 which has been
reported to play important role in the observed hydrogen bonding
network [9]. General-purpose all-atom force field (CHARMm)
with a wide coverage for proteins, nucleic acids and general
organic molecules was included in the random structure gener-
ation. 10 orientations were generated for the ATQ, improved by
performing simulated annealing method and finally refined by
applying low, but most accurate full potential as a refined pose
minimization method.
Molecular dynamics simulations
Molecular dynamics simulations were performed with Gromacs
ver. 4.5.3. The ligand topology and parameterization was attained
with SwissParam (http://www.swissparam.ch/), an automatic tool
that generates topology and parameters based on the Merck
molecular force field. The wild and mutant-type Cytbc1
complexes (Cyt b-ISP/ATQ) were subjected to molecular
dynamics simulation with explicit TIP3P water solvation model
in the Isothermal–isobaric (NPT) ensemble using the AM-
BER99SB force field. Each system was minimized with the
steepest descent method to relax unfavorable contacts between
molecules and equilibrated for 150 ps before production runs to
achieve stability during production dynamics. Simulations were
performed at a constant temperature of 310 K and pressure of 1
atm, using Particle Mesh Ewald method [23] for long-range
electrostatic [24] and van der Waals (vdW) [25,26] interactions
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with a cut-off of 1.4 nm while constraints were applied on all
bonds using the LINCS [27] algorithm. All systems were simulated
in the NPT (fixed number of atoms N, pressure P, and
temperature T) ensemble using the v-rescale coupling algorithm
[28] and the Parrinello–Rahman coupling algorithm [29] for
90 ns and time step of 2 fs without any position restraints.
MM/PBSA calculations
The MM/PBSA approach [30] was applied to perform the
binding free energy calculations. The binding free energy of a
protein to a ligand (DGbind) is defined from the complex, protein
and ligand free energies (Gcomplex, Gprotein and Gligand, respective-
ly) as [Eq. iii]
DGbind~ Gcomplex - (Gprotein z Gligand ) ð3Þ
Each free energy term is obtained from a MD-derived ensemble
of structures as the sum of six terms as mentioned in [Eq. iv].
vGw ~ vGintwzvGvdWwzvGcoulw
zvGpswzvGnpsw - TvSMMw
ð4Þ
Where Gint, GvdW and Gcoul indicate the internal (including
bond, angle, and torsional angle energies), van der Waals and
coulombic energy terms, respectively, collectively defined ‘‘gas
phase terms’’. ,Gps. and ,Gnps. are the polar and nonpolar
solvation energy terms, respectively. ,SMM. is the entropic
term. Angle brackets denote the average along the structures.
The single trajectory method (STM) has been used for both the
wild-type and the mutant systems. The STM requires the
trajectory of the complex to be run only. The structures of the
free forms of the protein and ligand species were obtained by
stripping the partner molecule from the structure of the complex.
Thus, zeroing out the ,Gint. term in the STM analysis.
For the MM/PBSA calculations, the GMXAPBS tool was used
[31]. In particular: (1) the van der Waals term was calculated with
Gromacs, (2) the coulombic term was calculated using the APBS
accessory program coulomb, (3) the polar solvation term was
calculated via APBS [32], using the non-linearized Poisson
Boltzmann equation. Internal and external dielectric constants
were set to 1 and 80, respectively; temperature was set to 310 K;
the salt concentration was defined as 0.15 M; grid spacing was set
to an upper limit of 0.5 A˚, (4) The nonpolar solvation term was
considered proportional to the solvent accessible surface area
(SASA) as shown in [Eq. v]
vGnpsw~ vSASAw czb ð5Þ
where c= 0.0227 kJ mol21 A˚22 and b= 0 kJ mol21[33]. The
dielectric boundary was defined using a probe of radius 1.4 A˚.
The equilibrium phase (70–90 ns) of the two molecular
dynamics simulations (i.e., 151 equally time-distant frames for
each system) was considered for MM/PBSA calculations. The
standard errors (SE) were calculated as [Eq. vi]
SE~SD=sqrt (151) ð6Þ
where SD is the standard deviation.
Principal component analysis
The Principal Component Analysis (PCA) was used to
characterize and compare the overall motions of the two
complexes. We calculated the principal components on the
converged simulation and focused on the movement of the 731
Ca atoms of the protein that resulted in 2193 dimensional
displacement vectors. The 219362193 covariance matrix was then
diagonalized to obtain its eigenvalues and eigenvectors. The PCA
method decomposes the overall protein motion into a set of modes
(eigenvectors) that are ordered from largest to smallest contribu-
tions to the protein fluctuations. The contribution of atom j to the
ith mode’s fluctuation was obtained using the following equation
[Eq. vii]:
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vectors of the jth atom for the ith mode.
Each of the eigenvectors depicts a collective motion of particles
and their respective amount of participation is represented by
eigenvalues. Usually, the first ten eigenvectors are sufficient to
describe almost all of the conformational subspace accessible to the
protein.
Results and Discussion
The Y268 residue of Cyt b in Plasmodium is known to play a
key role in ATQ drug resistance [8] and thus, can be used as a
potential resistance marker [34]. Studies of P. falciparum
resistance to ATQ revealed 3 point mutations at 268th position
(Y268N, Y268S, Y268C) [8,21,35]. The substitution of one or
several amino acid residues in a protein often lead to substantial
changes in properties such as thermodynamic stability, catalytic
activity, or binding affinity [36–38]. As point mutations at Y268
have already been identified for ATQ resistance, it is obvious that
this substitution should affect the fitting and binding of the drug.
ATQ drug, an analogue of coenzyme Q (ubiquinone), interrupts
electron transport and leads to loss of the mitochondrial
membrane potential [6].
Molecular modeling of Cyt b-ISP complex of P. falciparum
The 3D structure details of proteins are of major importance in
providing insights into their molecular functions. Since computa-
tional methods not only help in directing the selection of key
experiments, but also in the formulation of new testable
hypotheses [39]. Therefore, in the absence of X-ray structures,
the 3D theoretical models were built using the I-TASSER. I-
TASSER [12,13], a hierarchical protein structure modeling
approach based on 2 protein structure prediction methods i.e.,
threading and ab initio prediction, was used to build 3D models of
the Cyt b and ISP sequences from P. falciparum. I-TASSER uses
restraints from templates identified by multiple threading pro-
grams to build full length model using replica-exchange Monte-
carlo simulations. Cyt b chain was modeled by I-TASSER using
restraints from PDB templates 2IBZ, 3CX5, 1EZV, 1BCC and
3H1J while the ISP subunit used restrains from PDBs 1KB9,
3CX5, 1EZV, 1BCC, 3CWB, 1BGY and 3L72. No significant
similarity was observed with any of the PDB templates against N-
terminal sequence of ISP, therefore, this part was modeled by I-
TASSER using ab-initio approach. Although, including the long
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N-terminal sequence, modeled by ab-initio method can compro-
mise the overall model accuracy, in the present study, we used full
length model because of multiple reasons, (i) N-terminal 158
residues (modeled) of ISP subunit may also contribute in the
reliable folding of tertiary structure as we observed several
secondary structure elements in that region (Figure S1). Several
studies have shown that the removal of N-terminal building blocks
from the structure may contribute in error during protein folding
[40–42] as the protein may acquire a non-native stable confor-
mation due to mis-association of the adjunct building blocks. (ii)
After modeling of the Cyt b-ISP complex, we observed the N-
terminal sequence of chain moves back and forth over the active-
site cleft (Figure S2) therefore this part was also taken into
consideration. (iii) Since, even a single amino acid residue may
significantly affect the conformation of binding site if present
around 4.5 A˚ radius of the ligand, and may also alter the binding
efficacy [43], thus we preferred to include this region in our model,
so that the possible impact of N-terminal sequence in ATQ
binding may be evaluated during simulations.
The computation of a structural alignment of 2 protein
structures is critical in modeling, as in contrast to sequence
alignment methods, structure alignment methods aim directly on
optimizing the structural similarity of the input proteins [44]. The
implemented TM-score in I-TASSER is a sensitive scale to the
global topology for measuring the structural similarity between 2
proteins. Statistically, a TM-score ,0.17 means a randomly
selected protein pair with the gapless alignment taken from PDB.
The better TM-score of our Cyt b model (0.9960.04) and ISP
subunit model (0.3560.12) indicates much better structural match
of the target sequence with the templates. I-TASSER provides C-
score to estimate the quality of the predicted models, and is
calculated based on the significance (i.e. Z-score) of the threading
alignments in LOMETS and the convergence parameters (i.e.
cluster density) of the I-TASSER structure assembly simulations.
The C-score scheme has been extensively tested in large-scale
benchmarking tests [13,18] and is typically in the range (25, 2),
where a higher score reflects a model of better quality. The C-
score of the best predicted model of Cyt b and ISP subunit model
was +2.00 and 23.25.
The Side-Chain Refinement protocol of DS was used to
optimize the protein side-chain conformations. This protocol uses
ChiRotor algorithm and CHARMm force field to systematically
search for optimal side-chain conformation of all residues and
generates a model structure with the best side-chain conformation.
Model quality estimation is critically important in computational
protein modeling, since the accuracy of a model determines its
suitability for specific biological and biochemical experimental
design [45]. The fitness of a protein sequence in its current 3D
environment before and after side chain refinement was evaluated
by Verify Protein (Profiles-3D). The Verify score of the protein is
the sum of the scores of all residues in the protein and has been
used by several researchers for structural assessment of theoretical
models [46–48]. If the overall quality is lower than the expected
low score, the structure is certainly misfolded. The verify score of
the Cyt b model before and after energy minimization was 89.2
and 93.5, with the expected low score of 77.1, showing that the
structure after side chain refinement was much better than the
non-refined one. Similarly, we observed the verify score of the ISP
model as 89.4, with the expected low score of 72.7906. The exact
percentage of amino acids located in the core region was
calculated by Procheck program. Generally, the atomic resolution
structures have over 90% of their residues in the most favorable
regions and for lower resolution structures resolved at 3.0–4.0 A˚,
the core percentage is around 70% [49]. The Ramachandran plot
showed that 90.3% residues were located in the core region of Cyt
b chain and 83.33% residues were in the core region of ISP chain,
indicating the reliability of models for further studies (Figure S3).
Moreover, we also looked into the RMSD of the modelled Qo
site and the templates chosen for modeling of wild-type protein of
P. falciparum. The calculated residuals for 1EZV, 2IBZ, 3CX5,
3H1J and 1BCC templates from our modeled protein were
0.48 A˚, 0.44 A˚, 0.46 A˚, 0.56 A˚ and 1.02 A˚ respectively. The
insignificant RMSD of Qo site from the respective templates
further supports the model accuracy.
Mutagenesis of Cyt b protein
Most of the reported mutations in Cyt b either destabilize the
important hydrophobic interactions between ATQ and the amino
acid residues in the binding site of the protein, or are responsible
for the change of pocket volume [9,50]. The conserved bulky
Tyrosine (T) residue at 268th position forms hydrophobic contact
with the ATQ drug in the Qo region of the ubiquinol oxidation
site. Substitution of the hydrophilic and less bulky asparagine (N)
at position 268 not only reduces the volume of the binding pocket
but it also decreases the affinity and binding of ATQ [51]. Besides,
substitution of serine (S), a hydrophilic amino acid, limits
hydrophobic contact with ATQ resulting in marked decrement
of ATQ susceptibility in mutated malaria parasites [21,35].
Moreover, a role for cysteine (C) in impairment of ATQ binding
has also been observed [8]. Hence, P. falciparum Cyt b protein
mutations (Y268S, Y268N and Y268C) were implemented in the
3D structure of the parent model using mutational modeling
protocol of DS.
Active site selection and docking calculations of ATQ
ATQ is very likely to bind in a manner similar to stigmatellin, a
known inhibitor of Qo site of the Cyt bc1 complex [10] and hence
the potential binding site for stigmatellin as proposed by Solmaz
and Hunte (PDB acquisition code 3CX5) [20] was chosen as the
biologically favorable site for ATQ docking. After checking the
conservancy of the active site residues of Cyt bc1 complex of P.
falciparum (CYTB: MET116, ILE119, VAL120, PHE123,
VAL124, MET133, TRP136, GLY137, VAL140, ILE141,
THR142, LEU144, LEU145, ILE155, PHE169, LEU172,
ILE258, VAL259, PRO260, GLU261, PHE264, PHE267,
TYR268, LEU271, VAL284, LEU285; ISP: HIS104, LEU302,
CYS319) with the Cyt b protein of S. cerevisiae, we observed that
with the exception of 8 amino acid residues, all other residues were
conserved between these 2 species (Figure 1). Moreover, we
observed the non-identical residues of P. falciparum were also
showing strongly similar properties (scoring.0.5 in the Gonnet
PAM 250 matrix) with the amino acid residues present in S.
cerevisiae. Plasmodium Cyt b is unusual in the sense that cd2 helix
(a critical structural component of the catalytic Qo site) contains a
4-residue deletion that is not found in non-Apicomplexan
sequences. It would seem very likely that this would alter the fold
of the Qo site when compared to the Cyt b structural data
available in the PDB. Therefore, we aligned the 3D structures of
Cyt b from P. falciparum and S. cerevisiae. The structural overlay
of the homology model of the P. falciparum Cyt b with the yeast
Cyt b has been presented for comparison in Figure 2. Our model
suggests that the 4 residue deletion in the cd2 helix results in a
0.83 A˚ displacement of this structural element compared with the
yeast Cyt b (Figure 2). Likewise catalytically essential ‘PEWY’
motif of the ef helix was observed to be displaced by 0.35 A˚ from
the yeast enzyme. To perform docking analysis, the ATQ structure
was modeled properly using the Prepare/Filter Ligand tool of DS.
Docking is a potentially powerful and inexpensive method for the
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discovery of binary interactions. The Qo site residues were chosen
to define the binding site in our modeled Cyt bc1 complex of P.
falciparum based on known Qo site inhibitor interactions for S.
cerevisiae available in protein data bank (pdb id: 3CX5, 2IBZ). A
total of 10 random ligand conformations were generated from the
ATQ structure through high temperature molecular dynamics,
followed by random rotations. These conformations were refined
by grid-based (GRID 1) simulated annealing and a final full force
field minimization method. We observed that ATQ was showing
less binding affinity towards all the mutant variants when
compared to the wild-type.
Figure 1. Sequence alignment of Cyt b protein and ISP chain of P. falciparum and S. cerevisiae. Amino acid residues involved in the
formation of Qo site are highlighted in yellow tinted color.
doi:10.1371/journal.pone.0110041.g001
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While examining all the contact amino acid residues within 5 A˚
of the ATQ, as shown in the Figure 3, we observed the presence of
Y268 within the ATQ binding site in the wild-type protein.
Surprisingly when Y268 was mutated to any of the 3 possible
amino acid mutations, i.e.Y268N, Y268S, Y268C, this position
shifted far away from ATQ binding site. We feel the shift of amino
acid residue at 268th position after point mutation might be the
main reason of ATQ resistance in the mutant models. In order to
understand the mechanistic insight of ATQ resistance in the
mutant models, we further performed detailed molecular dynam-
ics simulation studies by considering only the most prevalent
mutant variant (Y268S) identified in various experimental settings
[9].
Dynamic insights into the Cyt bc1 modeled complexes
Several simulation studies have already shown nice correlation
between computational and experimental measurements of
macromolecular dynamics [52–55]. As molecular dynamics based
techniques can provide more precise protein–ligand models in the
state close to natural conditions therefore to get detailed insights
into the molecular basis of ATQ resistance in malaria, we
individually simulated ATQ-bound wild-type and the most
prevalent mutant variant (Y268S) of P. falciparum Cyt b protein
Figure 2. Structural overlay of the homology model of Cyt b protein of P. falciparum (blue) with the Cyt b unit of S. cerevisiae
(golden) (PDB ID: 3CX5). A total of 4 amino acid residues deletion in cd2 helix (red) of P. falciparum resulted in structural displacement when
compared with the same domain of S. cerevisiae (green). Also the structural changes in ‘PEWY’ motif of ef helix are shown.
doi:10.1371/journal.pone.0110041.g002
Figure 3. Two dimensional contact plots of amino acid residues from the wild and all screened mutant models of Cyt bc1 complex
from P. falciparum in the vicinity of 5 A˚ radius around ATQ. It may be noted that in the mutant models the position 268 shifted away from
the 5 A˚ radius of ATQ Binding site. Whereas green color indicates that the particular amino acid residue is present in the wild as well as in all mutant
models in the observed area; yellow, red, blue, cyan color shows amino acid residues present only in wild type, Y268S, Y268N and Y268C mutant
models respectively.
doi:10.1371/journal.pone.0110041.g003
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[9] till we attained the convergence of MD simulation around 70–
90 ns of production run. To explore the dynamic stability of the
systems, root mean square deviation (RMSD) of the Cyt b-ISP
backbone atoms (both wild-type and mutant complexes) was
computed with reference to their respective initial structures as a
function of simulation run time. MD simulation shows that the
wild-type complex undergoes less structural changes when
compared with the mutant complex over a period of 90 ns
simulation time (Figure 4A, in Cyan) and RMSD of both the
complexes remain almost stagnant after ,65 ns time period. The
plotted graph in Figure 4A (red) shows that although the RMSD
of mutant complex was initially in agreement with the wild-type
complex but the complex underwent significant deviation after 7ns
and reaches at ,1.1 nm RMSD (consistent throughout the whole
dynamics run), showing the comparatively unstable behavior of
the mutant complex. We further extended our study to analyze the
compactness (radius of gyration) of both the wild-type and mutant
complexes. Though we did not find much significant difference in
Rg values, however we noticed that at the equilibrium state
mutant structure was more compact than the wild-type (Fig-
ure 4B). We were also interested to check the ATQ distance from
the Qo site during the entire dynamics run. After analyzing the
results, we noticed that ATQ retained its position throughout the
whole dynamics run in the wild-type however it showed significant
fluctuations during the entire 90ns simulation in mutant case
(Figure 4C). Even as clear from the Figure 4C, the distance
between the Qo site and ATQ was increasing with respect to time.
We may attribute this behavior to the change in binding pocket
configuration and also because of some steric clashes of ATQ near
the binding site.
In order to understand how the resistant mutations affect the
interaction of ATQ in mutant protein, we calculated root mean
square inner product (RMSIP) from both the complexes to
ascertain the convergence of conformational sampling instep-wise
Figure 4. Molecular dynamics simulation graph of wild (Y268) and mutant (Y268S) Cyt bc1 complexes of P. falciparum in solution. (A)
Root mean square deviation (RMSD) of backbone atoms with respect to their initial complexes over a period of 90 ns simulation time. (B) Radius of
gyration (Rg) graph and (C) Distance of ATQ from the Qo site over the whole simulation in wild as well as mutant type.
doi:10.1371/journal.pone.0110041.g004
Figure 5. ATQ binding site in the wild and mutant (Y268S) Cyt bc1 complex of P. falciparum. The figure indicates that ATQ binds to a new
site in the mutant model which is around 12 A˚ distant from the Qo site. The structure was captured from the average structure of the Cyt bc1
complex of P. falciparum over 70–90 ns (converged part of the trajectory).
doi:10.1371/journal.pone.0110041.g005
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manner till we find the convergence. In this process, we increased
the production run from initial 20 to 90 ns in the block of 10 ns. In
general, RMSIP values between 0.5–0.7 represent adequate
convergence [56] and here in our case, we observed an acceptable
convergence measure of 0.55 from 70–90 ns trajectory. Therefore,
this part of simulation was used for the computation of average
structure of the complex. To remove the crudeness of the average
structure, the structure was subjected to 1000 steps of energy
minimization using the Smart Minimizer (SM) available in DS.
SM begins with the Steepest Descent method, followed by the
Conjugate Gradient method for faster convergence towards a
local minimum. We observed the ATQ interactions were
predominantly hydrophobic, although certain hydrophilic inter-
actions exist temporarily during the MD simulation. Histidine
residue 181 in the ISP (Yeast) is reported to form a strong
hydrogen-bond with certain classes of Qo-bound inhibitors such as
stigmatellin (’b-distal’ inhibitors). We noticed that in P. falci-
parum, HIS104 of ISP chain forms such stable interaction with the
ATQ. However, we did not find the stability of the ATQ hydrogen
bond that was supposed to be formed via a water molecule with
Glu (Glu-272 in yeast) of Cyt b. In mutant case, both these
interactions were altogether absent. In the mutant model
irrespective of ATQ binding at Qo site, it was found to get
stabilized at a new site (site II) which is around 12 A˚ apart from
Table 1. MM/PBSA binding free energies (kJ/mol) of wild-type and mutant Cyt bc1/ATQ complexes.
Binding free energies (kJ/mol) Y268S Y268
DGcoul
1 271.43861.993 249.33461.527
DGvdW
2 2188.38161.118 2209.54661.023
DGps
3 190.65062.357 246.72862.430
DGnps
4 217.92460.070 219.96260.037
DGpolar
5 119.212 197.394
DGnonpolar
6 2206.305 2229.508
DGbind
7 287.09462.178 232.11362.653
1: coulombic term;
2: van der Waals term;
3: polar solvation term;
4: nonpolar solvation term;
5: polar term (sum of coulombic and polar solvation terms);
6: nonpolar term (sum of van der Waals and nonpolar solvation terms);
7: computational binding free energy.
doi:10.1371/journal.pone.0110041.t001
Figure 6. Proportion of variance and cumulative proportion of total variance of first ten eigenvalues of the wild (Y268) and mutant
variant (Y268S) of P. falciparum proteins.
doi:10.1371/journal.pone.0110041.g006
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the Qo site. The two different binding modes of ATQ in wild and
mutant-type are shown in Figure 5. Moreover, we also noticed
that the induced mutation makes the active site to undergo
significant conformational changes that reduce both the active site
volume (7174.6 A˚3) and its surface area (4783.4 A˚2) than the wild-
type (11388 A˚3; 7269.3 A˚2). The shrinkage in both volume and
surface area (also reflected by Rg values, Figure 4C) might be also
one of the probable reasons for different binding site selectivity of
ATQ in mutant-type. Overall, all the above consequences might
be the causing agents for ATQ to have different selectivity in the
mutant protein than the wild-type.
MD-based binding free energy calculations of ATQ-
bound Cyt bc1 complex
To acquire an estimate of the binding free energies in the two
systems (i.e., Y268 and Y268S) and to inspect the differences in
terms of polar and non-polar interactions, we performed binding
free energy calculations on the converged MD trajectories (70–
90 ns) using the MM/PBSA approach. For this purpose, we took
advantage of the GMXAPBS tool [30]. Here we would like to
mention that in this investigation we were interested in highlight-
ing the differences of binding free energies of similar complexes. As
already reported for several other investigations [30,57,58], we will
thus ignore the entropic term and focus only on the binding
enthalpy, defined as the sum of 4 terms, namely coulombic, van
der Waals, polar solvation and non-polar solvation. The results of
our calculations are shown in Table 1.
Both systems present a similar pattern: the van der Waals,
coulombic and non-polar solvation terms are negative, meaning
that they favor the formation of the complex. On the contrary, the
polar solvation term is positive, which indicates that it antagonizes
the binding process. This observation might be due to the cost of
desolvating the polar moieties in the protein residues and in the
ligand. It is noteworthy that in both cases the polar contribution,
defined as the sum of the coulombic and the polar solvation terms,
is positive. Overall, the MM/PBSA analysis reveals that the
complex stabilization is promoted by the non-polar contribution
only. Such a behavior has been described in the past both for
protein-ligand [59] and for protein-protein [31] interactions. The
Y268S mutation significantly affects all terms.
Our study demonstrates that the binding of ATQ with the site II
(newly identified binding site) of P. falciparum Cyt bc1 complex
was energetically favorable compare to the site I (Qo site). We
assume the sufficient binding energy of ATQ at site II might be
preventing ATQ to bind its native site (Qo) thereby resulting in the
loss of the anti-malarial efficiency of ATQ in the Y268S mutant-
type.
Essential dynamics analyses of the Cyt bc1 complexes
To support the MD results, we performed essential dynamics
study of both the simulated complexes and our results shows that
the cumulative variance captured by the first few eigenvectors or
principal components of the wild-type complex was comparatively
lower than the mutant-type (Figure 6).
The analysis indicates that the Y268S/ATQ complex pertain
more motions than the wild-type complex. This is in consistent
with the earlier dynamic results where we observed some
fluctuations and far away displacement of ATQ from the Qo site
in the Y268S/ATQ complex.
Conclusion
The emerging acquired drug resistance because of mutations
has presented a challenge to follow the traditional drug discovery
pipelines. Even a single point mutation has potential to produce
the drug resistance. In this study, we evaluated the drug-resistance
mechanism of ATQ in the mutated (Y268S) Cyt b protein of P.
falciparum using the potential of in silico methods. We observed
that the interaction between ATQ and Cyt b is mainly stabilized
by the hydrophobic contacts and after mutation of Y268S ATQ
contacts with the Qo site are greatly reduced. Such findings have
also been reported by other authors [9]. We presume that this
reduction in Qo contacts and also change in the volume and
surface area of the binding pocket (similar observations have been
made by Kessl et al. 2005 [9] in I269M mutation of ATQ-bound
yeast bc1 complex) enforce ATQ to find its desirable contacts at
distant location from its wild active site. Moreover, the MM-PBSA
calculations firmly proved the tighter binding of ATQ with the
mutant-type at additional binding site (first time observation),
present at ,12 A˚ faraway from the active site, thereby raising no
choice for ATQ to bind its native site. This might be the probable
reason for ATQ anti-malarial efficacy loss in Y268S mutants. We
hope the structural details presented in this study would aid the
experimental plan to design new suitable selective ligands that
could have correct size to fit properly in the active site even after
mutation. Such ligands might be able to resist the mutation effect
and can be used as future effective drugs against malaria.
Supporting Information
Figure S1 ISP subunit of Cyt bc1 complex of P. falciparum with
predicted secondary structure elements. It is important to note that
the initial 158 N-terminal residues, which were not present in the
S. cerevisiae Cyt bc1 complex subunit in PDB file 3CX5, are also
involved in critical secondary structure confirmations. This is the
reason why we consider full length ISP subunit in our analysis.
(TIF)
Figure S2 The Qo site (ATQ binding site) of Cyt bc1 complex of
P. falciparum is shown. The N-terminal residues of ISP chain are
involved in the formation of active site (Qo) cleft (red color and
shown as surface model). Cyt b subunit is shown in green color
and ISP subunit as blue.
(TIF)
Figure S3 The Ramachandran plots of modeled Cyt b protein
and ISP subunit of P. falciparum in Cyt bc1 complex are shown.
The plots indicate the quality of the modeled structure was
satisfactory.
(TIF)
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